InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Gaynor Richard, Director. Insider active across 2 companies, notably Zai Lab Ltd. Aggregated, 16 filings have been published. Split: 2 buys · 2 sells. Total volume traded: €184k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 1 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gaynor Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
1,736 shares@ US$19.050.0015% mcap4.3% of flowAmerican Depositary SharesSEC:0000905148-26-003169:0
Canonical exit: 29 Sept 2026 (T+90)
6,142 sharesOrdinary SharesSEC:0001520262-26-000084:0
1,475 shares@ US$36.950.0010% mcap100.0% of flowOrdinary SharesSEC:0001520262-26-000084:1
1,731 shares@ US$18.910.0012% mcap50.0% of flowAmerican Depositary SharesSEC:0000905148-26-001398:0
Canonical exit: 15 Jun 2026 (T+90)
10,831 shares0American Depositary SharesSEC:0000905148-25-002217:0
8,013 sharesOrdinary SharesSEC:0001127602-25-016198:0
2,500 shares@ US$35.0712.8% of flowAmerican Depositary SharesSEC:0000905148-25-000873:0
2,500 shares@ US$19.506.9% of flowAmerican Depositary SharesSEC:0000905148-24-002519:0
6,104 sharesOrdinary SharesSEC:0001127602-24-019594:0
21,253 shares0American Depositary SharesSEC:0000905148-24-001753:0
5,957 sharesOrdinary SharesSEC:0001127602-23-020547:0
18,903 shares@ US$26.4571.5% of flowAmerican Depositary SharesSEC:0000950170-23-031095:0
7,585 sharesOrdinary SharesSEC:0001127602-22-017637:0
5,578 sharesOrdinary SharesSEC:0001127602-21-030302:0
8,912 shares0Ordinary SharesSEC:0000899243-21-045487:0
6,104 shares0Ordinary SharesSEC:0001127602-21-017788:0
16 of 16 declarations
About Gaynor Richard
Richard Gaynor is a Director at Zai Lab Ltd and Alkermes plc. He brings valuable expertise in corporate governance and strategy. As a board member, he is involved in overseeing the operations and strategic decisions of the companies. His experience in the pharmaceutical and biopharmaceutical sectors enables him to effectively contribute to the growth and innovation of the organizations he serves.
